GLP-1 Receptor Agonists Among Patients With Overweight or Obesity, Diabetes, and HFpEF on SGLT2 Inhibitors
Related Posts
Miyazaki Y, Park YM, Rimmer M, Miyazaki K, Yamagami S, Izawa Y, Osai N, Hanna P, Fishbein MC, Shivkumar K, Mori S. Understanding Cardiac Anatomy[...]
Jafarvand M, Farolfi A, Mei R, Djaileb L, Benz M, Chung A, Brisbane W, Marks L, Grogan T, Gafita A, Theus L, Nguyen AT, Czernin[...]
Mora R, Irannejad K, Abbas N, Mogga P, Iskander B, Hubbard L, Roy S, Lakshmanan S, Budoff M, Krishnan S. Emerging quantitative CCTA imaging biomarkers[...]